Sugi Predict

Sugi Predict / Compounds / SCHEMBL2467283

SCHEMBL2467283

SCHEMBL2467283

C=CCCc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.52
▸ LMNA P02545 1/20 0.43
▸ TSHR P16473 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ NT5E P21589 1/20 0.42
▸ CA2 P00918 9/20 0.40
▸ CA1 P00915 5/20 0.40
▸ CA12 O43570 3/20 0.40
▸ CA4 P22748 3/20 0.40
▸ CA6 P23280 3/20 0.40
▸ CA5A P35218 3/20 0.40
▸ CA7 P43166 3/20 0.40
▸ CA9 Q16790 3/20 0.40
▸ CA14 Q9ULX7 3/20 0.40
▸ CA5B Q9Y2D0 3/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP2D6 P10635 2/20 0.36
▸ F2 P00734 2/20 0.36
▸ TMPRSS4 Q9NRS4 2/20 0.36
▸ POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819892 0.86 CA2 (0.46) TDP1LMNATSHRALDH1A1NT5E
SCHEMBL11583429 0.81 LMNA (0.56) TDP1LMNATSHRALDH1A1NT5E
SCHEMBL1698660 0.81 CA2 (0.60) CA2CA1CA12CA4CA6
SCHEMBL29129905 0.81 ALDH1A1 (0.40) TDP1TSHRALDH1A1CA2CA1
SCHEMBL8014528 0.81 LMNA (0.43) TDP1LMNATSHRALDH1A1NT5E
SCHEMBL87584 0.80 TDP1 (0.55) TDP1LMNATSHRALDH1A1NT5E
Ammonia Solution, Strong SCHEMBL6669195 0.78 TDP1 (0.53) TDP1LMNATSHRALDH1A1NT5E
SCHEMBL4132583 0.78 TDP1 (0.53) TDP1LMNATSHRALDH1A1NT5E
Sulfuric Acid SCHEMBL15238309 0.78 MAPT (0.52) TDP1LMNAALDH1A1CA2CA1
SCHEMBL9004469 0.78 GFER (0.36) TDP1TSHRALDH1A1CA2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535684-B2 Chitosan derivatives and methods for preparing the same PRIMEX EHF. (IS) 2022-12-27 — — US claimed
US-20210253745-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME PRIMEX EHF. (IS) 2021-08-19 — — US claimed
EP-3841129-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME Haskoli Islands (IS) 2021-06-30 — — EP claimed
WO-2020039463-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME HASKOLI ISLANDS (IS) 2020-02-27 — — WO claimed
EP-0898556-B1 A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS MINNESOTA MINING & MFG (US) 2001-12-12 — — EP claimed
EP-0898556-A1 A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-03-03 — — EP claimed
US-5750797-A CONTACTING A FLUORINATED CARBONYL-CONTAINING COMPOUND WITH AN ALKYLATING AGENT IN THE PRESENCE OF AN ANHYDROUS SOURCE OF FLUORIDE ION AND A TERTIARY AMINE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-05-12 — — US claimed
WO-1997038962-A1 A PROCESS FOR THE PRODUCTION OF HYDROFLUOROETHERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-10-23 — — WO claimed
US-4771034-A LEUCO DYE, SALICYCLIC ACID DERIVATIVE AS ELECTRON ACCEPTOR FUJI PHOTO FILM CO., LTD. (JP) 1988-09-13 — — US claimed
US-20230151121-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME PRIMEX EHF. (IS) 2023-05-18 — — US disclosed
US-11535684-B2 Chitosan derivatives and methods for preparing the same PRIMEX EHF. (IS) 2022-12-27 — — US disclosed
US-20210253745-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME PRIMEX EHF. (IS) 2021-08-19 — — US disclosed
EP-3180317-B1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME (US) 2021-04-14 — — EP disclosed
EP-3180327-B1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME (US) 2019-05-08 — — EP disclosed
EP-0025973-A2 Porous semipermeable membrane based on polyacrylonitrile modified by amidoxime groups, process for its preparation and their use ALIGENA AG (CH) 1981-04-01 — — EP disclosed
US-4146509-A ORGANIC AMMONIUM COMPOUNDS USED AS POLYMERIZATION CATALYSTS BAYER AKTIENGESELLSCHAFT (DE) 1979-03-27 — — US disclosed
US-4075343-A Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof PFIZER INC. (US) 1978-02-21 — — US disclosed
US-4066766-A 1-Oxo-6-substituted pyrimido [1,2-a]quinoline-2-carboxylic acids and derivatives thereof and their use as antiallergy agents PFIZER INC. (US) 1978-01-03 — — US disclosed
US-4031217-A PYRIMIDINE-QUINOLINE COMPOUNDS PFIZER INC. (US) 1977-06-21 — — US disclosed
US-4014881-A ANTIULCER AGENTS PFIZER INC. (US) 1977-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151121-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME MGMT, CHIA, ALG1 TDP1 1201/4885LMNA 1186/4885TSHR 3002/4885
US-11535684-B2 Chitosan derivatives and methods for preparing the same MGMT, CHIA, ALG1 TDP1 1201/4885LMNA 1186/4885TSHR 3002/4885
US-20210253745-A1 CHITOSAN DERIVATIVES AND METHODS FOR PREPARING THE SAME MGMT, CHIA, ALG1 TDP1 1201/4885LMNA 1186/4885TSHR 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.